Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry
Reference21 articles.
1. Dearden CE (2007) Role of antibody therapy in lymphoid malignancies. Br Med Bull 83:275–290
2. Motta G, Cea M, Moran E, Carbone F, Augusti V, Patrone F, Nencioni A (2010) Monoclonal antibodies for non-Hodgkin’s Lymphoma: state of the art and perspectives. Clin Dev Immunol.
https://doi.org/10.1155/2010/428253
3. Brouwers AH, van Eerd JEM, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC (2004) Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. J Nucl Med 45:327–337
4. Beckford Vera DR, Eigner S, Eigner Henke K, Lebeda O, Melichar F, Beran M (2012) Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors. Nucl Med Biol 39:3–13
5. Milenic DE, Garmestani K, Chappell LL, Dadachova E, Yordanov A, Ma D, Schlom J, Brechbiel MW (2002) In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications. Nucl Med Biol 29:431–442
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献